approval
saveANASTROZOLE — FDA approval
community read0 votes
Sponsor: SANDOZ. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalANASTROZOLE — FDA approvalOct 24, 2025 · 346d ago
- approvalANASTROZOLE — FDA approvalFeb 21, 2025 · 591d ago
- approvalANASTROZOLE — FDA approvalNov 5, 2015 · 3987d ago
- approvalANASTROZOLE — FDA approvalNov 5, 2015 · 3987d ago
- approvalANASTROZOLE — FDA approvalAug 13, 2015 · 4071d ago
- approvalANASTROZOLE — FDA approvalAug 13, 2015 · 4071d ago
- approvalANASTROZOLE — FDA approvalNov 28, 2011 · 5425d ago
- approvalANASTROZOLE — FDA approvalNov 14, 2011 · 5439d ago
same company · ±60 days · 6
- approvalDIFLUPREDNATE: DUREZOL (DIFLUPREDNATE) — FDA approvalOct 27, 2025
- approvalJUBBONTI: JUBBONTI (DENOSUMAB-BBDZ) — FDA approvalOct 29, 2025
- approvalnatalizumab biosimilar: TYRUKO (NATALIZUMAB-SZTN) — FDA approvalOct 30, 2025
- approvalHYRIMOZ: HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalOct 16, 2025
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalNov 6, 2025
- approvalTRAVOPROST: TRAVATAN Z (TRAVOPROST) — FDA approvalOct 9, 2025
comments(0)
5-min edit window · permanent after that